Perseus Proteomics Inc. (4882.T)

JPY 610.0

(-0.65%)

Long Term Debt Summary of Perseus Proteomics Inc.

  • Perseus Proteomics Inc.'s latest annual long term debt in 2023 was - JPY , down 0.0% from previous year.
  • Perseus Proteomics Inc.'s latest quarterly long term debt in 2024 Q1 was - JPY , down 0.0% from previous quarter.
  • Perseus Proteomics Inc. reported annual long term debt of - JPY in 2022, down 0.0% from previous year.
  • Perseus Proteomics Inc. reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • Perseus Proteomics Inc. reported quarterly long term debt of - JPY for 2023 Q2, down 0.0% from previous quarter.
  • Perseus Proteomics Inc. reported quarterly long term debt of - JPY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Perseus Proteomics Inc. (2023 - 2019)

Historical Annual Long Term Debt of Perseus Proteomics Inc. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%

Peer Long Term Debt Comparison of Perseus Proteomics Inc.

Name Long Term Debt Long Term Debt Difference
Kyowa Kirin Co., Ltd. 15.71 Billion JPY 100.0%
Astellas Pharma Inc. 447.73 Billion JPY 100.0%
Chugai Pharmaceutical Co., Ltd. 6.48 Billion JPY 100.0%
Ono Pharmaceutical Co., Ltd. 6.55 Billion JPY 100.0%
Santen Pharmaceutical Co., Ltd. 27.46 Billion JPY 100.0%
JCR Pharmaceuticals Co., Ltd. 14.35 Billion JPY 100.0%
Daiichi Sankyo Company, Limited 101.31 Billion JPY 100.0%
Otsuka Holdings Co., Ltd. 69.2 Billion JPY 100.0%